This study used inhaled endotoxin ( LPS ) challenge as a model of innate immune activation to ( @ ) assess the safety of the IL-@ receptor antagonist anakinra in conjunction with inhaled LPS and ( @ ) to test the hypothesis that IL-@ blockade will suppress the acute neutrophil response to challenge with inhaled LPS .